FOI_6521

Internal Reference Number: FOI_6521

Date Request Received: 15/03/2022 00:00:00

Date Request Replied To: 23/03/2022 00:00:00

This response was sent via: By Email

Request Summary: Oesophageal and Gastric Cancer

Request Category: Companies


Question Number 1: How many patients were treated in the past 3 months for gastric and gastro-oesophageal junction cancer (any stage) with: • CAPOX (Capecitabine with Oxaliplatin) • FOLFOX (Folinic acid, Fluorouracil and Oxaliplatin) • Pembrolizumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Any other systemic anti-cancer therapy • Palliative care only

Answer To Question 1: Capox 0 FOLFOX below 5 Pembro with platinum 0 Other SACT below 5

Question Number 2: How many patients were treated in the past 3 months for Oesophageal cancer (any stage) with: • Pembrolizumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidine (5-Fluorouracil or Capecitabine) • Platinum and Fluoropyrimidine based combination treatments (Cisplatin or Oxaliplatin with 5-Fluorouracil or Capecitabine) • Nivolumab monotherapy • Nivolumab and Ipilimumab • Any other systemic anti-cancer therapy • Palliative care only

Answer To Question 2: Pembro plus platinum 0 Platinum plus fluoropyrimidine below 5 Nivolumab 0 Niv/Ipi 0 Other SACT below 5 We are unable to answer the question for palliative care only.

Question Number 3: Does your trust participate in any active clinical trials for the treatment of gastric cancer or cancer of the gastro-oesophageal junction? If so, can you please provide the name of each trial and the number of patients taking part.

Answer To Question 3: The Trust does not currently participate in any active clinical trials for the treatment of gastric cancer or cancer of the gastro-oesophageal junction.

Question Number 4: Does your trust participate in any active clinical trials for the treatment of oesophageal cancer? If so, can you please provide the name of each trial and the number of patients taking part.

Answer To Question 4: The Trust does nor currently participate in any active clinical trials for the treatment of oesophageal cancer

To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.